Back to Search
STEVEN GRANT, PHARMD, RPH
PHARMD, RPH
Pharmacist
NPI: 1699321380Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Is the focus moving toward a combination of targeted drugs?
PMID 19041602·Best Pract Res Clin Haematol·2008
6-review
Simultaneous interruption of signal transduction and cell cycle regulatory pathways: implications for new approaches to the treatment of childhood leukemias.
PMID 17584030·Curr Drug Targets·2007
6-review
The novel histone deacetylase inhibitor NVP-LAQ824: an addition to the therapeutic armamentarium in leukemia?
PMID 15496978·Leukemia·2004
7-preclinical
Gene profiling and the cyclin-dependent kinase inhibitor flavopiridol: what's in a name?
PMID 15252148·Mol Cancer Ther·2004
6-review
Activation of MAP kinase pathways by TRAIL: don't expect the obvious.
PMID 15107606·Cancer Biol Ther·2004
8-other
The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapy.
PMID 12654284·Drug Resist Updat·2003
6-review
A chicken-or-egg conundrum in apoptosis: which comes first? Ceramide or PKCdelta?
PMID 11901179·J Clin Invest·2002
8-other
The role of signal transduction pathways in drug and radiation resistance.
PMID 12481713·Cancer Treat Res·2002
6-review
Roles of ERBB family receptor tyrosine kinases, and downstream signaling pathways, in the control of cell growth and survival.
PMID 11815285·Front Biosci·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 298 SW 18TH ST
RICHMOND, IN 47374 - Phone
- (765) 962-5032
Quick Facts
- NPI
- 1699321380
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile